Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers

Molecular Therapy(2020)10.1016/j.ymthe.2020.12.019Source: DataRank Database

ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers is a research paper published in Molecular Therapy (2020). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: hybridTopics (17)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Anne Campbell,Ashley Pandolf,Troy Rogerson,Qing Zhong ORCID,Aizhen Xiao

Live enrichment

PubMed:33333291

National Science Foundation

Grant: 1511853

UNS: Developing Quantitative Models of SHP2-Mediated Signaling regulation in Glioma for Rational Identification of Improved Therapeutic Approaches.

National Science Foundation

Grant: DGE-1321851

National Institutes of Health

Grant: P30CA044579

American Cancer Society

Grant: RSG-15-010-01-CDD

National Cancer Institute

Grant: 1R21CA252576-01

Engineering ERK-specificity for cancer suicide gene therapy

National Science Foundation

Grant: 1321851

Graduate Research Fellowship Program (GRFP)

National Institutes of Health

Grant: 3P30CA044579-19S1

Cancer Center Support Grant

hybridLicense: CC BY NC ND

publisherhttps://api.elsevier.com/content/article/PII:S1525001620306766?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001620306766?httpAccept=text/plain

https://doi.org/10.1016/j.ymthe.2020.12.019

https://pubmed.ncbi.nlm.nih.gov/33333291

https://dx.doi.org/10.1016/j.ymthe.2020.12.019

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Genetic VectorsGenes, Transgenic, SuicideGenetic TherapyThymidine KinaseCytosine DeaminaseMiceNeoplasmsTumor Cells, Culturedras ProteinsAnimalsHeterograftsHumansSimplexvirusExtracellular Signal-Regulated MAP Kinases

Sustainable Development Goals

SDG 3: 3. Good health